Skip to main content
Contact

Put an objective motor endpoint in your next trial

Three ways to start, from lowest to highest commitment. Most sponsor conversations begin with the briefing and end with NeuroQuantix pre-specified as an exploratory endpoint in a study that is already being planned.

Book a 20-minute technical briefing

Bring your indication and current endpoints. You leave with a view of which kinematic metrics would be pre-specified for your mechanism, what the power math looks like, and whether a pilot makes sense. No slides, no pitch.

Pick a time

Read the Scientific Brief

Evidence, metrics, protocol, and compliance in one document. Three fields, no call required.

Get the brief

Request a pilot evaluation

Scope NeuroQuantix as an exploratory endpoint in one upcoming study or a sub-study. Use the form and choose the pilot option.

Start a pilot request

Send a message

David McLaughlin, Founder & CEO
David McLaughlin
Founder & CEO, Cerebral Innovations LLC
40+ CNS clinical trials

Every message goes to David, not a sales queue. Replies within one business day.

david@cerebral-innovations.com
St. Petersburg, Florida. Working with sponsors in North America and Europe.

What happens next

  1. 1You get a reply from David within one business day with two or three questions about your indication and current endpoints.
  2. 2A 20-minute briefing: which metrics would be pre-specified for your mechanism, the power math, and site workflow.
  3. 3If it fits, a written pilot scope for one study: endpoint definition language, integration plan, and timeline.